NanoViricides
NNVC
NNVC
27 hedge funds and large institutions have $2.45M invested in NanoViricides in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
41% less capital invested
Capital invested by funds: $4.13M → $2.45M (-$1.68M)
Holders
27
Holding in Top 10
–
Calls
$74K
Puts
$4K
Top Buyers
| 1 | +$167K | |
| 2 | +$67.5K | |
| 3 | +$19.8K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$1K |
Top Sellers
| 1 | -$108K | |
| 2 | -$53K | |
| 3 | -$51K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$23K |
| 5 |
BlackRock
New York
|
-$2.92K |